Navigation Links
ResMed Receives Injunctions against APEX and BMC in Germany, Continues Enforcement of Patents in Europe
Date:11/20/2013

DUSSELDORF, Germany, Nov. 20, 2013 /PRNewswire/ -- ResMed (NYSE: RMD), an innovator and pioneer in developing products for the treatment of sleep-disordered breathing and respiratory conditions, has won preliminary injunctions in Germany against several patent infringing activities by Taiwanese medical device manufacturer APEX Medical Corp. (APEX) and Chinese medical device manufacturer BMC Medical Co., Ltd. (BMC).  The initial orders, entered by the Munich District Court, prohibit APEX and BMC from selling or marketing certain products in Germany without a further court order.  Those products are:

  • The APEX WiZARD 210 and WiZARD 220 mask headgear
  • BMC's  RESmart CPAP devices
  • BMC's Willow/FeaLite nasal pillows patient interface
  • ResMed has also filed patent infringement lawsuits in Munich, Germany, seeking damages and permanent injunctions to stop infringement of ResMed patents by the products listed above, as well as the additional products below: 

  • The APEX iCH and XT Fit CPAP devices
  • The APEX WiZARD 210 and WiZARD 220 masks
  • Earlier this year, ResMed pursued similar legal actions against APEX and BMC in the United States with the International Trade Commission (ITC). The U.S. government investigation started at ResMed's request against APEX resulted in an ITC consent decree against APEX stopping the importation and sale of infringing APEX products. Proceedings against BMC are ongoing.

    "ResMed has a global business built on its investment in research and development, resulting in products that excel in performance, quality and comfort," said David Pendarvis, ResMed global general counsel and chief administrative officer. "We will continue to defend our investment in intellectual property and pursue all legal remedies to prevent infringement in any country where that infringement exists."

    About ResMed:
    ResMed is a global leader in the development, manufacturing and marketing of medical products for the diagnosis, treatment and management of respiratory disorders, with a focus on sleep-disordered breathing. The company is dedicated to developing innovative products to improve the lives of those who suffer from these conditions and to increasing awareness among patients and healthcare professionals of the potentially serious health consequences of untreated sleep-disordered breathing. For more information on ResMed, visit www.resmed.com.

    (Logo:  http://photos.prnewswire.com/prnh/20100203/RESMEDLOGO)Contacts:For News Media For the Investor CommunityGretchen Griswold

    Constance BienfaitDirector, Global Corporate Communications

    Director, Investor RelationsO: 858-836-6789 

    O: 858-836-5971news@resmed.com

    constance.bienfait@resmed.com


    '/>"/>
    SOURCE ResMed Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Related medicine technology :

    1. ResMed Inc. Announces Plan To Initiate Dividend And Update On Chief Executive Officer Succession
    2. ResMed Launches Narval™ CC Mandibular Repositioning Device in the US
    3. ResMed Announces Conference Call And Webcast To Discuss Fourth Quarter And Fiscal Year-End 2012 Results
    4. ResMed Inc. Announces Record Financial Results For The Quarter And Twelve Months Ended June 30, 2012
    5. ResMed Inc. Announces Record Financial Results for the Quarter Ended September 30, 2012
    6. ResMed Inc. Announces Exchange Rate For Upcoming Dividend Payment
    7. ResMed Inc. Announces Record Financial Results For The Quarter Ended And Six Months Ended December 31, 2012
    8. Buoyed by Forecasts, Where 2013 Leads - Research Report on ResMed Inc., Zimmer Holdings, Inc., Waters Corporation, Covidien PLC, and Medtronic, Inc.
    9. ResMed Takes Action to Enforce Patents
    10. ResMed Announces Conference Call And Webcast To Discuss Third Quarter 2013 Results
    11. ResMed Noninvasive Ventilation Device Cleared by FDA for COPD Treatment
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/21/2017)... Md. and RESEARCH TRIANGLE PARK, ... Therapeutics Corporation (NASDAQ: UTHR ) announced today ... results before the market opens on Thursday, July 27, ... will host a teleconference on Thursday, July 27, 2017, ... by dialing 1-877-351-5881, with international callers dialing 1-970-315-0533.  A ...
    (Date:7/17/2017)... Fla. , July 17, 2017  MedX Holdings, ... branded medical testing, strengthening and rehabilitation equipment, today announced ... Machine Program. MedX is considered the gold standard for ... leader in specialized medical strengthening equipment. ... a lease with the physician or practice who prescribe ...
    (Date:7/13/2017)... July 13, 2017 RK Logistics Group, Inc. was ... certification for its Fremont, CA headquarters ... the Tri-Valley and San Jose for ... of Fremont , with its Fremont Innovation District, is ... such a powerful resource to the hundreds of biotech, pharma ...
    Breaking Medicine Technology:
    (Date:7/24/2017)... ... July 24, 2017 , ... Cheerag D. Upadhyaya , M.D., M.Sc., FAANS ... Institute (SLMBNI), part of Saint Luke’s Health System . Dr. Upadhyaya has ... Upadhyaya, MD. M.Sc., FAANS joins Stanley P. Fisher, M.D., who has served ...
    (Date:7/24/2017)... ... 24, 2017 , ... BayMark Health Services has been awarded ... (SAMHSA) State Targeted Response to the Opioid Crisis program. The funding, awarded ... development of a hub and spoke model for opioid treatment in California. The ...
    (Date:7/24/2017)... ... 2017 , ... Peruvian Ayahuasca retreat, East West Lodge, announced ... and divided between two full-time university students enrolled in U.S. or Canadian accredited ... apply for the scholarship, students are asked to submit an essay between 750 ...
    (Date:7/24/2017)... ... 2017 , ... Axiad IDS , a leading provider of trusted identities ... WALLIX to expand its solution to help government contractors more quickly and cost-effectively ... ways to address the authentication requirements within NIST SP800-171, but no matter how ...
    (Date:7/24/2017)... ... July 24, 2017 , ... A CDC study shows that, although people are taking more ... 18 to 29), had at least one case of sunburn within the past year. It’s ... people to ignore the issue. However, only recently have people become conscientious of the risks ...
    Breaking Medicine News(10 mins):